Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    "Spinal Muscular Atrophy Type 2"
Show Display Options
Rank Status Study
1 Terminated
Has Results
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
Conditions: Spinal Muscular Atrophy Type II;   Spinal Muscular Atrophy Type III
Intervention: Drug: sodium phenylbutyrate
2 Completed Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)
Condition: Spinal Muscular Atrophy
Intervention: Other: Functional tests
3 Completed Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.
Conditions: Spinal Muscular Atrophy Type II;   Spinal Muscular Atrophy Type III Non Ambulant
Interventions: Drug: Olesoxime;   Drug: Placebo
4 Recruiting SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4
Conditions: Spinal Muscular Atrophy;   SMA;   Kugelberg-Welander Disease
Interventions: Drug: Pyridostigmine;   Drug: Placebo
5 Completed Pilot Study of Growth Hormon to Treat SMA Typ II and III
Condition: Muscular Atrophy, Spinal
Interventions: Drug: somatotropin;   Drug: Placebo
6 Unknown  Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)
Condition: Spinal Muscular Atrophy
Intervention:
7 Completed A Pilot Study of Biomarkers for Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Intervention:

Study has passed its completion date and status has not been verified in more than two years.